OSTEONECTIN AND SELECTED BIOMARKERS IN ATHEROSCLEROTIC OCCLUSION AND CALCINOSIS OF CORONARY ARTERIES
Abstract
Blood levels of osteonectin (a protein marker of stromal stem cells with osteogenic potential) were measured, using the method of biomagnetic protein separation with magnetic microspheres, in 45 men with coronary atherosclerosis and 45 age-matched controls without coronary heart disease. Osteonectin concentration was maximal in men with atherosclerotic stenosis (AS) and calcinosis of coronary arteries. Osteonectin levels were independently associated with several key markers of atherosclerosis, metabolic syndrome, and coronary AS and calcinosis. Therefore, osteonectin could be one of the new markers of coronary AS and calcinosis.
About the Authors
Yu. I. RaginoRussian Federation
E. V. Kashtanova
Russian Federation
A. M. Chernyavsky
Russian Federation
A. M. Volkov
Russian Federation
Ya. V. Polonskaya
Russian Federation
M. V. Ivanova
Russian Federation
References
1. Габбасов З.А., Агапов А.А., Сабурова О.С. и др. Определение циркулирующих стромальных стволовых клеток с остеогенной потенцией в крови пациентов с ишемической болезнью сердца методом лазерной поточной цитометрии // Бюлл. эксп. биол. мед., 2005; 139 (2): 237-240.
2. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. IV пересмотр. Москва, ВНОК // Кардиоваск. тер. и проф., 2009; 6 (Прил. 3), 58 с.
3. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin // Circ. Res., 2004; 95 (11): 1046-1057.
4. Gabbasov Z.A., Agapov A.A., Saburova O.S. et al. Circulating stromal osteonectin-positive progenitor cells and stenotic coronary atherosclerosis // Can. J. Physiol. Pharmacol., 2007; 85(3-4): 295-300.
5. Gadeau A.P., Chaulet H., Daret D. et al. Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury // J. Histochem. Cytochem., 2001; 49: 79-86.
6. Gossl M., Modder U.I., Atkinson E.J. et al. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis // J. Am. Coll. Cardiol., 2008; 52(16): 1314-1325.
7. Hunt J.L., Fairman R., Mitchell M.E. et al. Bone formation in carotid plaques: a clinicopathological study // Stroke, 2002; 33: 1214-1219.
8. Ibebuogu U.N., Ahmadi N., Hajsadeghi F. et al. Measures of coronary artery calcification and association with the metabolic syndrome and diabetes // J. Cardiometab. Syndr., 2009; 4(1): 6-11.
9. Messika-Zeitoun D., Bielak L.F., Peyser P.A. et al. Aortic valve calcification: determinants and progression in the population // Arterioscler. Thromb. Vasc. Biol., 2007; 27: 642-648.
10. Tabet F., Rye K.A. High-density lipoproteins, inflammation and oxidative stress // Clin. Sci., 2009; 116 (2): 87-98.
11. Trion A., van der Laarse A. Vascular smooth muscle cells and calcification in atherosclerosis // Am. Heart J., 2004; 147(5): 808-814.
12. Wong N.D., Sciammarella M.G., Polk D. et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium // J. Am. Coll. Cardiol., 2003; 41: 1547–1553.
Review
For citations:
Ragino Yu.I., Kashtanova E.V., Chernyavsky A.M., Volkov A.M., Polonskaya Ya.V., Ivanova M.V. OSTEONECTIN AND SELECTED BIOMARKERS IN ATHEROSCLEROTIC OCCLUSION AND CALCINOSIS OF CORONARY ARTERIES. Russian Journal of Cardiology. 2010;(4):20-23. (In Russ.)